These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10544300)

  • 1. Estrogen in the etiopathogenesis of BPH.
    Farnsworth WE
    Prostate; 1999 Dec; 41(4):263-74. PubMed ID: 10544300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgens and estrogens in benign prostatic hyperplasia: past, present and future.
    Nicholson TM; Ricke WA
    Differentiation; 2011; 82(4-5):184-99. PubMed ID: 21620560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M; Bartsch W; Thomsen M; Voigt KD
    J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and experimental studies of benign prostatic hyperplasia.
    Coffey DS; Walsh PC
    Urol Clin North Am; 1990 Aug; 17(3):461-75. PubMed ID: 1695775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical localization of estrogen receptors in spontaneous and experimentally induced canine benign prostatic hyperplasia.
    Schulze H; Barrack ER
    Prostate; 1987; 11(2):145-62. PubMed ID: 2444954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of estrogen and SHBG in prostate physiology.
    Farnsworth WE
    Prostate; 1996 Jan; 28(1):17-23. PubMed ID: 8545277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and androgen signaling in the pathogenesis of BPH.
    Ho CK; Habib FK
    Nat Rev Urol; 2011 Jan; 8(1):29-41. PubMed ID: 21228820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine control of benign prostatic hyperplasia.
    La Vignera S; Condorelli RA; Russo GI; Morgia G; Calogero AE
    Andrology; 2016 May; 4(3):404-11. PubMed ID: 27089546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of estrogens in human benign prostatic hyperplasia.
    Sciarra F; Toscano V
    Arch Androl; 2000; 44(3):213-20. PubMed ID: 10864369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histologic components of benign prostatic hypertrophy (bph) in relation to the androgen-estrogen status (author's transl)].
    Seppelt U; Buhl K; Drews M
    Urologe A; 1978 Mar; 17(2):117-9. PubMed ID: 76360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia.
    Partin AW; Oesterling JE; Epstein JI; Horton R; Walsh PC
    J Urol; 1991 Feb; 145(2):405-9. PubMed ID: 1703242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Androgen and estrogen metabolism in human benign prostatic hyperplasia (BPH)].
    Krieg M; Weisser H; Tunn S
    Verh Dtsch Ges Pathol; 1993; 77():19-24. PubMed ID: 7511279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogens and Male Lower Urinary Tract Dysfunction.
    Wynder JL; Nicholson TM; DeFranco DB; Ricke WA
    Curr Urol Rep; 2015 Sep; 16(9):61. PubMed ID: 26156791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia.
    McPherson SJ; Ellem SJ; Simpson ER; Patchev V; Fritzemeier KH; Risbridger GP
    Endocrinology; 2007 Feb; 148(2):566-74. PubMed ID: 17068134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative disorders of the aging human prostate: involvement of protein hormones and their receptors.
    Untergasser G; Rumpold H; Hermann M; Dirnhofer S; Jilg G; Berger P
    Exp Gerontol; 1999 Apr; 34(2):275-87. PubMed ID: 10363793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcript profiling of the androgen signal in normal prostate, benign prostatic hyperplasia, and prostate cancer.
    Bauman DR; Steckelbroeck S; Peehl DM; Penning TM
    Endocrinology; 2006 Dec; 147(12):5806-16. PubMed ID: 16959841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex steroids and epidermal growth factor in benign prostatic hyperplasia (BPH).
    Sciarra F
    Ann N Y Acad Sci; 1995 Jun; 761():66-78. PubMed ID: 7542859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
    Wang W; Zhang X; Mize GJ; Takayama TK
    Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atamestane: an aromatase inhibitor for the treatment of benign prostatic hyperplasia. A short review.
    el Etreby MF
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):565-72. PubMed ID: 7682838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.